Franklin Resources’s Janux Therapeutics JANX Stock Holding History

Franklin Resources’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Buy	105,281 +15,180	+17%	+$220K	﹤0.01%	2087
2026 Q1	$1.25M	Sell	90,101 -295,200	-77%	-$4.05M	﹤0.01%	2088
2025 Q4	$5.32M	Sell	385,301 -502,454	-57%	-$11.8M	﹤0.01%	1375
2025 Q3	$21.7M	Sell	887,755 -181,440	-17%	-$4.42M	0.01%	929
2025 Q2	$24.7M	Sell	1,069,195 -117,284	-10%	-$3.09M	0.01%	864
2025 Q1	$32M	Buy	1,186,479 +689,192	+139%	+$26M	0.01%	751
2024 Q4	$26.6M	Buy	497,287 +478,304	+2,520%	+$25.3M	0.01%	814
2024 Q3	$937K	Buy	18,983 +7,442	+64%	+$324K	﹤0.01%	2016
2024 Q2	$483K	Buy	+11,541	New	+$542K	﹤0.01%	2241

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Franklin Resources's JANX Position: Q2 2026 in Review

Franklin Resources increased its Janux Therapeutics (JANX) stake by 17% in Q2 2026, buying an estimated $220K and bringing the position to 105,281 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

Franklin Resources first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. The position peaked at $32M in Q1 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Franklin Resources held 105,281 shares of Janux Therapeutics worth $1.62M as of Q2 2026.
Franklin Resources bought 15,180 Janux Therapeutics shares in Q2 2026, an estimated $220K.
Janux Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2087 holding.
Franklin Resources first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
Franklin Resources's Janux Therapeutics position peaked at $32M in Q1 2025.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.